Literature DB >> 1095607

Studies concerning the antibiotic actinonin. Part VIII. Structure-activity relationships in the actinonin series.

B J Broughton, P Chaplen, W A Freeman, P J Warren, K R Wooldridge, D E Wright.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1095607

Source DB:  PubMed          Journal:  J Chem Soc Perkin 1        ISSN： 0300-922X


× No keyword cloud information.
  6 in total

1.  Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.

Authors:  J M Clements; R P Beckett; A Brown; G Catlin; M Lobell; S Palan; W Thomas; M Whittaker; S Wood; S Salama; P J Baker; H F Rodgers; V Barynin; D W Rice; M G Hunter
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics.

Authors:  Myongjae Lee; Yoo-Seong Jeong; Min-Soo Kim; Kyung-Mi An; Suk-Jae Chung
Journal:  Pharmaceutics       Date:  2022-05-28       Impact factor: 6.525

3.  Solvent-assisted slow conversion of a dithiazole derivative produces a competitive inhibitor of peptide deformylase.

Authors:  Alexander K Berg; Qingfeng Yu; Steven Y Qian; Manas K Haldar; D K Srivastava
Journal:  Biochim Biophys Acta       Date:  2009-11-14

4.  Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach.

Authors:  D Chen; C Hackbarth; Z J Ni; C Wu; W Wang; R Jain; Y He; K Bracken; B Weidmann; D V Patel; J Trias; R J White; Z Yuan
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

5.  Comparative QSAR studies on peptide deformylase inhibitors.

Authors:  Ji Young Lee; Munikumar Reddy Doddareddy; Yong Seo Cho; Hyunah Choo; Hun Yeong Koh; Jae-Hoon Kang; Kyoung Tai No; Ae Nim Pae
Journal:  J Mol Model       Date:  2007-02-27       Impact factor: 2.172

Review 6.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.